9Kacprzak-Berqman I,Nowakowska B.Influence of genetic factors on the susceptibility to HBV infection,its clinical pictures,and responsiveness to HBV vaccination[J].Arch Immunol Ther Exp (Wars2),2005,53 (2):139-142.
10CooremanaMP,Leroux-RoelscG,Paulijb WP.Vaccine and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen[J].J Biomed Sci,2001,8 (3):237-247.
4Mohammad Irshad. Nucleic acid hepatitis B virus (HBV) vaccine :current status. Hepalology Research , 1998,13 : 71 - 79.
5Ueda K,Tsurimot T,Matsubara K,et al.Three envelope proteins of hepatitis B virus large S,middle S,and major S proteins needed for the formation of Dane particles. J Virol, 1991,65(4) :3521 - 3529.
6Valenzuela P, Medina A, Butter WJ, et al. Synthesis and assembly of hepatitis B surface antigen particles in yeast. Nature, 1982,298:347 - 350.
7Wands JR, Liang TS, Blum HE, et al. Molecular pathogenesis of liver disease during persistent hepaltits B virus infection. Semin Liver Dis, 1992,12(3) :252 - 264.
8Neurath AR, Kent SBH, Parker K, et al. Antibodies to a synthetic peptide from the pre120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine, 1986b,4 : 35.
9Geert LR, Isabelle D, Luc C, et al. Hepatits B vaccine containing surface antigen and selected preS1 and preS2 seuences. 2.Immunogenicity in poor responders to hepatitis B vaccines.Vaccine, 1997,15(16) : 1732 - 1736.
10Chisari FV, Ferrari C. Hepatitis B virus immunpathogensis. Annu Rev Immunol, 1995,13 : 29.
